Directed neutrophil migration to IL-8 is increased in cystic fibrosis: a study of the effect of erythromycin.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 11120907.
- Also identified by PMC identifier 1745912.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this study was to compare neutrophil migration in cystic fibrosis (CF) and non-CF populations and to investigate the effect of erythromycin on directed migration of neutrophils (PMNs) in CF. PMNs were isolated and their migratory capacity in response to interleukin-8 (IL-8) or f-Met-Leu-Phe (fMLP) in the presence or absence of erythromycin (1-100 microg/ml) was assessed. CF derived PMNs showed significantly increased migration to IL-8 but not to fMLP compared with non-CF PMNs. Erythromycin had no significant effect on migration responses to IL-8 and in vitro exposure of PMNs to erythromycin had no effect. CF derived PMNs show higher migratory responsiveness to IL-8 but not to fMLP, suggesting that CF PMNs may be "primed" to IL-8 which is significantly increased in CF serum compared with non-CF serum. Treatment with erythromycin had no significant effect on PMN migration in vitro.
Medical subject headings
- Anti-Bacterial Agents
- Chemotaxis, Leukocyte
- Cystic Fibrosis
- Erythromycin
- Interleukin-8
- Neutrophils